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During evolution in an aerobic environment, multicellular organisms survived by adaptive responses
to both the endogenous oxidative metabolism in the cells of the organism and the chemicals and
low-level radiation to which they had been exposed. The defense repertoire exists at all levels of the
biological hierarchy-from the molecular and biochemical level to the cellular and tissue level to the
organ and organ system level. Cells contain preventive antioxidants to suppress oxidative damage
to membranes. Cells also contain proteins and DNA; built-in redundancies for damaged molecules
and organelles; tightly coupled redox systems; pools of reductants; antioxidants; DNA repair
mechanisms and sensitive sensor molecules such as nuclear factor kappa beta; and signal
transduction mechanisms affecting both transcription and post-translational modification of proteins
needed to cope with oxidative stress. The biologic consequences of the low-level radiation that
exceeds the background level of oxidative damage could be necrosis or apoptosis, cell proliferation,
or cell differentiation. These effects are triggered by oxidative stress-induced signal transduction
mechanisms-an epigenetic, not genotoxic, process. If the end points of cell proliferation,
differentiation, or cell death are not seen at frequencies above background levels in an organism, it
is unlikely that low-level radiation would play a role in the multistep processes of chronic diseases
such as cancer. The mechanism linked to homeostatic regulation of proliferation and adaptive
functions in a multicellular organism could provide protection of any one cell receiving deposited
energy by the radiation tract through the sharing of reductants and by triggering apoptosis of target
stem cells. Examples of the role of gap junctional intercellular communication in the adaptive
response of cells and the bystander effect illustrate how the interaction of cells can modulate the
effect of radiation on the single cell. Environ Health Perspect 106(Suppl 1):331-339 (1998).
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Evolution of Homeostatic social dimensions, as ahierarchy ofsuch
natural systems interconnected by various Regulation of Multicellular patterns ofinformation flow in feedback
Organisms in Hostile circuits. "Health" may then be defined as
Environments the harmonious interaction ofall hierar-
chical components, while "disease" is the
From Laszlo's analysis ofliving things as result of a force which perturbs or dis-
natural systems one may develop a view rupts hierarchical structure. The systems
of man, in both the individual and approach clarifies the relations among
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the biological and social sciences, points
out the need for new concepts of med-
ical practice, and suggests directions for
closer contact between science and
ethics. Further development of the sys-
tems view may yield significant results,
both practical and theoretical (1).
One ofthe most difficult scientific iand
social/political issues to resolve today is:
What are the biologic and health conse-
quences to the human being and to society
after low level exposures to radiation and
toxic chemicals? Given that direct scientific
data cannot provide the answers to these
questions, many assumptions and extrapo-
lated experimental and epidemiologic data
currently are being used to derive various
risk-assessment models. However, because
our current understanding ofthe cowplex
nature of the interactions of genetics,
development, sex, diet, lifestyle, drug, and
environmental pollutant factors intm the
induction ofvarious chronic somatic dis-
eases as well as hereditary diseases, it seems
that the relevance of the risk-assessment
models is scientifically questionable.
To derive a more biologically based
risk-assessment model we will examine
some ofthe relevant fundamental concepts
in the evolution ofmulticellular organisms
as related to the induction ofvarious dis-
eases by radiation and chemical toxicants.
Life originated in a hostile environment.
As primitive life forms evolved they did so
in the presence ofpotentially harmful tadi-
ation and chemical toxicants. Ironically,
humans as a species and as individuals
evolved in an environment basically hostile
to its very existence.
From the single fertilized egg through
sexual maturation and reproduction to
aging and death, the human being is not
just approximately 100 trillion individual
cells but a tightly orchestrated collection of
different cell types (pluripotent stem cells,
committed progenitor cells, and terminally
differentiated cells) organized into tissues,
organs, and organ systems and regulated by
a cybernetic feedback ofpositive and nega-
tive signals (1,2). The normal external
environment where this evolution, exis-
tence, survival, and reproductive success
occurs contains a background level ofboth
radiation and chemical toxicants.
For most organisms including humans,
the energy for life is derived in an oxy-
genated atmosphere by oxidative metabo-
lism that produces many potentially lethal
reactive oxygen species (ROS) (2,3).




Togetherwith background nonionizing and
ionizing radiations as well as various chemi-
cals that interact with the organism, addi-
tional ROS are generated. Single-cell
organisms developed a series ofprotective
mechanisms to respond to both exogenous
and endogenously created potentially lethal
toxicants. Clearly the maintenance ofthe
genetic integrity for adaptive survival ofthe
single cells, as well as the survival of the
species, is paramount. Protection against
DNA damage by various intracellular bio-
chemical and DNA repair mechanisms
(4,5) evolved to cope with the ambient and
supra-ambient levels ofphysical and chemi-
cal toxicants. Both viable and lethal muta-
tions can occur when the protective and
repair mechanisms are breached. Death to
both the single cell and the species could
also occur by non-DNAdamage; that is, by
the destruction ofsubcellular organelles
(e.g., membranes, mitochondria) by these
toxicants (6).
The transition ofthe single-cell organism
to the multicellular organism was accompa-
nied by differentiation ofcell types, which
led to the development ofvarious tissues,
organs, and organ systems. In other words
organization ofsingle cells into collections of
cells allowed the emergence ofnew protec-
tive and repair mechanisms at the cellular,
tissue, organ, and system levels not found in
the single cellular organism. Whereas the
single-cell organism survived by its ability to
proliferate, the multicellular organism sur-
vived and proliferated (e.g., in wound heal-
ing and redundancy ofcells in tissues) by
having differentiated functions and struc-
tures at all system levels and with adaptive
responses ofthe genome to stress-induced
signal transduction mechanisms (7-10).
Homeostatic control ofcell proliferation,
differentiation, and adaptive response ofdif-
ferentiated cells in multicellular organisms is
dependent on three forms ofcommunica-
tion: extra junctional, intra junctional, and
gap junctional intercellular communication
(GJIC) (11) (Figure 1). Whereas single-cell
organisms respond to extracellular signals
that trigger various intracellular signals (sig-
nal transducing mechanisms), the multicel-
lular organism has the additional ability to
homeostatically control cells coupled
together bythe membrane-associated protein
channel gap junction (12,13). It is through
gap junction channels that ions and low-
molecular-weight molecules can freely pass,
thereby allowing an equilibration ofregula-
tory ions and molecules (14). Gapjunctions
can serve as sinks or point sources for critical
cellular molecules (15).
The absence ofgap junctions in single-
cell organisms, and their presence in mul-
ticellular organisms, coincides with the
evolutionary difference in the abilities of
unicellular and multicellular organisms to
survive and adapt. Specifically it has been
speculated that the emergence ofhigher
order biologic levels ofcellular organiza-
tion (e.g., tissues, organs, organ systems)
and their homeostatic control ofcell pro-
liferation, differentiation, development,
wound repair, and adaptive responses of
differentiated cells was dependent on the
appearance ofthe gap junction gene (16).
In other words, the evolution ofdifferenti-
ation was causally related to the evolution
of the gap junction gene. A family of
highly evolutionarily conserved gap junc-
tion genes has been identified (13). Strong
circumstantial evidence links the presence
of functional gap junctions with growth
control and differentiation (12).
Ifthese gap junctions do play a major
role in homeostatic regulation ofcells in a
multicellular organism and ifhomeostasis is
the mechanism regulating health of the
organism, then the question of risks with
low-level exposures to various toxicants must
involve an examination ofhow low-level
exposures might affect GJIC-dependent
homeostasis (17,18).





All living organisms are threatened by the
use ofoxidative metabolism to generate
energy because ofthe potentially lethal reac-
tive oxygen metabolites and inescapable
exposure to radiation and exogenous chemi-
cals capable ofgenerating ROS. Various
mechanisms have evolved in unicellular and
multicellular organisms to cope with ambi-
ent (background) and induced levels of
oxidative stress. In unicellular organisms the
single cell must cope with potentially lethal
levels ofoxidative stress-induced changes.
The single cell ofthe unicellular organism is
the unit oflife. However, the unit oflife or
unit offunction in a multicellular organism
is really the syncytium ofgap junctionally
coupled cells (19).
In the multicellular organism the cells
have developed various redox systems
as well as compartmentalization and
Gapjunction
3 Intercellular communication
Figure 1. Heuristic schema characterizing the postulated link between extracellular communication and intercellu-
lar communication via various intracellular transmembrane signaling mechanisms. This framework provides an
integrated view of how the neuroendocrine-immune system (mind or brain and body connection) and other multi-
system coordinations could occur. Although not shown here, activation or altered expression of various oncogenes
and antioncogenes could also contribute to the regulation of gap junction function. Reproduced from Trosko et al.
(95), bypermission of Elsevier Science Ireland Ltd.
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damping strategies to cope with the
inevitable generation ofROS.
To understand how low-level exposures
ofradiation or chemicals might affect mul-
ticellular organisms, several concepts must
be considered. Photons or chemicals inter-
act at the atomic or molecular levels of
multicellular organisms (20). The events
that occur within a cell after exposure to
radiation and chemical toxicants may affect
any number ofmolecules and/or organelles.
Depending on the protective mechanisms
of the organisms (e.g., melanin, drug-
metabolizing enzymes, glutathione and
antioxidant levels, redundancy oforganelles
such as multiple mitochondrion), and
repair mechanisms, i.e., DNA excision
repair enzymes, exposures might have little
probability ofdisrupting the normal func-
tion. Moreover the type ofcell at the time
ofexposure must be considered. Totipotent
or pluripotent stem cells, committed prog-
enitor cells, and terminally differentiated
cells will respond differently to the same
exposure because the state ofdifferentia-
tion will provide varying degrees ofprotec-
tion and repair. The biologic consequences
of exposures ofthese cells to various toxi-
cants will be different. For example if a
pluripotent stem cell ofa given tissue is
hypersensitive to radiation, as is noted for
murine small intestinal stem cells when
compared to the stem cells of the large
intestine (21), then differential oncogenesis
might be expected.
If gene or chromosomal mutation
frequencies in cells that survive radiation or
chemical carcinogenic exposure are differ-
ent in stem cells when compared to their
differentiated daughter cells because ofthe
differential apoptosis or necrosis rates of
these cell types (22), then using in vitro
genotoxicity assays without recognizing
these confounding influences will lead to
misleading risk assessments.
The impact of radiation or chemicals
must exceed a background level to which
the cells, tissues, organs, and organism nor-
mally have evolved and developed. Natural
oxidative metabolism for life and natural
exposures to background levels ofradiations
and toxicants in all environments create the
noise levels that set the natural life span and
disease spectra for each species. Artificial
experimental control ofthe normal dietary
habits of rodents, for example via caloric
restriction, can dramatically affect both life
span and disease spectra (23,24). Iflow-
level exposure to particular radiations or
chemical toxicants does not induce molecu-
lar events that exceed background levels
in a multicellular organism, the biological
riskwill be canceled out by the normal risks
ofliving.
The chain ofevents within the cell after
exposure to low levels of radiation and
chemicals permits oxidative reactions to
occur. If such events exceed the normal
capacity ofthe cell to quench these chemi-
cal reactions, a number ofsignal transduc-
tion mechanisms can be triggered (18,19).
Depending on the type, cycle, and cell pro-
liferative state (apoptosis or necrosis), differ-
entiation or adaptive responses are possible
biologic consequences ofoxidative stress-
induced signal transduction. With oxida-
tive stress and the biologic response ofthe
cell in a multicellular organism, both tran-
scriptional and post-translational modifica-
tion of gene expression (25-28) and
modulation ofGJIC can occur (29,30).
The prevailing paradigm assumes that all
biologic consequences oflow-level exposures
to radiation and toxic chemicals are geno-
toxic because at higher doses these same
agents can induce genetic damage in some
cases (linear-no threshold dose-response
model). However, current evidence indi-
cates epigenetic mechanisms are induced
by these agents. Ultraviolet ionizing radia-
tion and chemical mutagens and carcino-
gens can induce gene expression (8,31-35),
modulate cell-cell communication (36,37),
cause apoptosis without DNA damage (38),
and effect transformation in vitro (39) or
carcinogenesis in vivo without genotoxicity
(40). Even in cases where DNA lesions can
be detected by one technique or another,
mutations measured in some short-term
assay, or mutations detected in oncogenes
found in tumors formed after exposure to a
chemical carcinogen, questions remain as to
whether these lesions and mutations are





As the age of the median life span has
increased in developed countries, it has been
estimated that one out offour individuals
will develop some type of cancer before
death. All ofus are exposed from concep-
tion to both physical and chemical agents
that can contribute to the carcinogenic
process (a background level plus any incre-
ment above background because ofgenetic
sensitivity differences, lifestyle differences, or
accidental, deliberate, or unknowing expo-
sures to physical and/or chemical agents).
Therefore, the question remains as to how
these exposures, both long-term low-level
chronic exposures and acute higher levels,
might contribute to the ultimate appearance
ofcancer.
Several concepts of the carcinogenic
process must be integrated, as currently
no one theory seems complete (11). The
stem cell theory (cancer as a disease of
differentiation or oncogeny as partially
blocked ontogeny), the initiation/pro-
motion/progression theory, the onco-
gene/tumor suppression theory, and the
hierarchical/cybernetic theories were all
derived by a number ofunique empirical
observations related to cancer. For exam-
ple: a) not all cells in an organism seem
able to give rise to neoplastic cells (42); b)
cells of a given tumor appear monoclonal
in origin (43); c) cells of tumors display
varying degrees ofdifferentiation without
being able to terminally differentiate (44);
d) tumor cells do not contact inhibit or do
not have normal growth control (45); e)
tumor cells have activated oncogenes and
dysfunctional tumor suppressor genes
(46); andf) tumor cells do not have nor-
mal positive or negative growth-regulator
responses (47).
Recognizing that universal acceptance of
each ofthese views ofcarcinogenesis is not a
given [see stem cell theory vs the theory of
dedifferentiation (48)], we assume that
weight ofthe evidence gives substantial cred-
ibility to each theory but that no one theory
can explain all ofthe empirical evidence
related to the carcinogenic process or cancer
phenotypes. Therefore, assuming each ofthe
aforementioned theories is based on solid
empirical and experimental data with regard
to either the phenotypes ofcancer cells or
the carcinogenic process, it seems that GJIC
could be the integrating factor that ties all of
these incomplete theories together.
The carcinogenic process appears to
involve the evolution ofa pluripotent stem
cell, which has the ability to terminally dif-
ferentiate and proliferate and maintain its
stemness, into a cell that starts to differen-
tiate but is partially blocked during the dif-
ferentiation process (Figure 2). This block
might be considered the initiation phase.
That is, the first step ofthe carcinogenic
process prevents the mortalization or ter-
minal differentiation of a stem cell (49).
The concept runs counter to the prevailing
idea that the early step ofcarcinogenesis
involves the immortalization of a normal
mortal cell (50). The partially differenti-
ated initiated stem cell still has the ability
to proliferate. Experimental evidence with
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Figure 2. The initiation/promotion/progression model of carcinogenesis. , rate of terminal differentiation and
death of stem cell; P2, rate of death but not ofterminal differentiation ofthe initiated cell; al, rate of cell division
of stem cells; a2, rate of cell division of initiated cells; p,, rate of the molecular event leading to initiation (i.e.,
possibly mutation); P2, rate at which second event occurs within an initiated cell. Reproduced from Trosko et al.
(95), bypermission ofJohnWiley and Sons, Inc.
mouse skin cells is consistent with such a
hypothesis. The observations ofNakano
et al. (42), that only a small subset ofcells
in Syrian hamster embryos is able to be
neoplastically transformed, also is consis-
tent with the hypothesis. Moreover, stem-
like cells have recently been isolated from
normal human kidney (51) and breast
epithelial tissue (52).
During the evolution ofthe initiated cell
to a malignant, invasive, and metastatic
tumor, the cells of the tumor acquire the
phenotypes ofmalignancy (12,53). Whereas
cancers usually contain cells with many dif-
ferent abnormal genotypes (an indication of
genomic instability), evidence indicates that
these cells had aclonal origin (43).
One can infer from the tumor promo-
tion studies on liver, skin, bladder, and
breast tissues that the single initiate stem
cell is growth suppressed by either extra-
cellular communication negative growth
regulators such as transforming growth
factor beta (TGF-P), and/or GJIC or
both. The rationale for this idea comes
from observations that animals initiated
with a subthreshold dose of a carcinogen
can live their lives without developing any
tumors. Only after chronic and regular
exposure to noninitiating tumor promot-
ers can latent tumors appear (54). Most
tumor promoters and tumor-promoting
conditions (i.e., wounding, cell-killing
compensatory mechanisms) inhibit GJIC
(55) and block apoptosis (56,57).
Inhibition in GJIC would allow the initi-
ated stem cell to escape the suppressing
effects ofsurrounding normal cells (58).
By starting to differentiate, these initiated
stem cells could be expressing specific gap
junctions more closely related to the early
stages of differentiation. Therefore, they
are able to communicate with themselves
(homologous communication) but not
with the surrounding normal cells that
express another connexin gene and are
communicating homologously but not
heterologously with the initiated cell. The
fact that these benign initiated cells have
some growth control via homologous
GJIC could result from communicating
with the normal cells by extracellular neg-
ative growth regulators such as hormones
orTGF-P-like factors.
Tumor promoters can both inhibit
GJIC (58) and modulate growth factor
receptors (59) as well as trigger various
intracellular communication or signal
transduction systems (60). As long as gap
junctions are downregulated by exogenous
tumor-promoting chemicals or mitogenic
endogenous growth factors and hormones,
the initiated cells can proliferate. These
clones ofabnormal partially differentiated
cells form the nodules of the breast,
enzyme-altered foci ofthe liver, papillomas
ofthe skin, andpolyps ofthe colon. During
the clonal expansion process caused by the
tumor-promoting effect ofdownregulating
GJIC and extracellular communication, if
other changes occur that downregulate the
function ofgap junctions stably (e.g., acti-
vation ofsome oncogene, deactivation ofa
tumor-suppressor gene, mutation ofextra-
cellular regulators ofgap junctions such as
TGF-P, or mutation ofthe gap junction
gene), then an exogenous or endogenous
source of an inhibitor ofGJIC would no
longer be needed. Even the genomic dys-
function of cell adhesion molecules or
extracellular matrix molecules would pre-
vent GJIC even in the absence ofany dys-
function ofgap junction genes and their
regulators. Cells that do not adhere do not
have GJIC.
The proposed role ofGJIC in carcino-
genesis might explain the multistep nature
of the process and why it seems easier to
induce leukemias than solid tumors. In the
former case the progenitor cells in the lym-
pho-reticular system downregulate the gap
junctions during normal differentiation to
produce free-existing, differentiated cells.
In otherwords normal differentiation elim-
inates one of the two major mitotic sup-
pressing mechanisms that exist. These
lympho-reticular free-existing progenitor
cells can still communicate through extra-
cellular positive and negative signals (e.g.,
cytokines, interferons, interleukins, etc.).
Normal stem cells communicate with their
differentiated daughters by extracellular
growth regulators (61-65), whereas their
differentiated progenitors communicate by
gap junctions and extracellular growth reg-
ulators. Therefore to escape mitotic sup-
pression both of these systems must be
downregulated by either or both mutagenic
or stable epigenetic mechanisms.
Evidence in support ofthis hypothesis
exists. Most, ifnot all, cancer cells are char-
acterized by dysfunctional homologous or
heterologous communication. Most, ifnot
all, tumor-promoting chemicals inhibit
GJIC reversibly. Growth factors and hor-
mones, which act as tumor promoters,
inhibit GJIC. Oncogenes such as ras, rafJ
neu, mos, and src can downregulate GJIC.
Tumor-suppressor genes can upregulate
GJIC. Tumor cells transfected with various
connexin genes can have their GJIC and
growth regulation restored. Antisense con-
nexin genes can downregulate GJIC and
antitumor promoters and chemopreventive
chemicals can upregulate GJIC (11).
Environmental Health Perspectives * Vol 106, Supplement 1 *February 1998 334OXIDATIVE STRESS MODULATION OF HOMEOSTASIS
The broad and integrating role ofgap
junctions in maintaining homeostatic con-
trol and acting as a mechanistic link in a sys-
tems model ofhuman health is illustrated in
three human genetic syndromes: Charcot-
Marie-Tooth syndrome, Visceroatrial
Heterotaxia syndrome, and mucoepithelial
dysplasia syndrome (66-68). In addition,
gap junction dysfunction has been linked to
many disease states such as arrhythmias,
cataracts, hypertension, and birth defects
(69-75). In fact many chemicals that mod-
ulate GJIC have been associated with terato-
genesis and neuro-, reproductive, and
immune toxicities (36). Although these
generalizations might seem implausible, one
must remember that gap junctions are
found in all tissues of the multicellular
organism and that virtually every intracellu-
lar regulatory ion/molecule, as well as many
signal transduction systems, have been
involved in the up- or downregulation of
GJIC. Gap junction genes and proteins have
become very sensitive to internal and exter-
nal factors that alter the steady-state oxida-
tive metabolism ofthe cell. Perturbations of
that background level could cause GJIC-
mediated regulation ofcell proliferation,
differentiation, apoptosis, and adaptive
responses ofdifferentiated cells to change.
Therefore, from the standpoint ofthe
initiation/promotion/progression theory of
carcinogenesis, the dysfunction of GJIC
plays a role primarily during promotion and
progression phases. Downregulation by
exogenous chemical promoters or endoge-
nous growth factors and hormones must a)
occur after a threshold level has been
exceeded (76-78), b) be sustained in a reg-
ular and chronic fashion (79), and c) be
potentially interrupted or reversed by chem-
icals that prevent downregulation or actually
induce upregulation ofGJIC (11) or by the
absence ofthe tumor promoter. Ifandwhen
stable downregulation ofGJIC occurs by
mutation in the connexin genes or the genes
regulating the connexins or in the epigenetic
transcription ofthese genes, an exogenous
or endogenous source oftumor-promoting
agents is no longer needed.
In summary, when we want to know if
a given agent is a carcinogen we must ask
ifthe agent initiates, promotes, or causes
the stable conversion or progression of the
tumor cell. Ifthe agent initiates it must sta-
bly prevent a stemlike cell from terminally
differentiating without blocking its ability
to proliferate. Whether initiators can induce
stable blockage of terminal differentiation
of stemlike cells without exceeding a
threshold level of exposure is not known.
The stemlike cells must be mitotically
regulated, and in the case of cells from
solid tissues they must have GJIC. Immortal
stemlike cells have been prevented from
mortalizing or terminally differentiating by
the initiation process. Ifthe given carcino-
gen is unable to stably initiate cells (i.e., it
is not a genotoxicant or mutagen) but is
able to bring about the selective prolifera-
tion ofthe initiated cell, then the carcino-
gen acts as a tumor promoter by triggering
a signal-transducing pathway in cells after
the carcinogen exceeds a threshold or back-
ground level. The organism or initiated cell
must be exposed to the promoting condi-
tion in a sustained fashion for a long period
of time in the absence of antipromoting
agents. Ifa given carcinogen can convert a
preexisting benign tumor cell to become
stably independent ofexogenous orendoge-
nous promoters such that the cell no longer
has functional GJIC then the agent can be
considered a progressor. Mutagens proba-
bly would be initiators. Epigenetic agents
would be considered promoters and antipro-
moters depending on whether they down-
or upregulate GJIC. Conceivably both
mutagens and epigenetic agents that could
bring about the stable downregulation of
GJIC would be progressors. With genetic,
developmental, and sex-related factors as
potential modulators of how diet, work-
place, lifestyle, and pollutants affect each of
the phases ofcarcinogenesis, it is impossi-
ble to predict accurately on an individual
basis the risk associated with exposure to
any given agent. Moreover, realistically, as
exposure is never by a single agent, additiv-





Adaptive Responses, and Pre-
and Postmodifying Factors
Although exposures to acute or chronic
high levels of radiation and chemicals in
experimental animal or epidemiologic
studies have yielded information regarding
the potential ofthese agents to cause vari-
ous human diseases and the mechanisms by
which they might be induced, extrapolation
to low-level chronic exposures has been
hampered by the inability either to conduct
statistically significant experiments or to
collect sufficient epidemiological data.
Consequently, models have been generated
that assume a linear, no-threshold relation-
ship between exposure to carcinogens and
the disease end point. At the same time
several challenges, both theoretical and
experimental, have been made that are
based on the assumption that thresholds
and molecular/biochemical, cellular, and
physiological mechanisms exist that are
not consistent with a one-hit model for
the actions of mutagens, cytotoxicants, or
epigenetic agents to determine ifthe agent
is a mutagen or not. The challenge is not
trivial (41).
Ifwe wish to determine what might
happen to an organism when it is exposed
to alowlevel ofacarcinogen, the terms level
and carcinogen must be understood.
Implicit in such terms are the concepts of
thresholds or linear responses to the agent of
concern and of initiators, promoters, and
progressor (genotoxic, cytotoxic, and epige-
netic) agents. Clearly all organisms are
chronically exposed to low level or back-
ground levels ofpotential carcinogenic ini-
tiators and promoters. As discussed earlier
normal organisms have evolved adaptive
mechanisms to cope with this background
noise. Therefore low-level exposure implies
that the level ofexposure that is above the
background level does not easily lead to a
causally linked biological or disease end
point but could induce a molecular, cellular,
or physiologic response. The implication is
that the multicellular organism can adap-
tively respond to signals induced byphysical
and chemical agents without incurring any
irreversible or irreparable damage.
The many levels ofbiologic organiza-
tions in the hierarchical systems ofa multi-
cellular organism provide at least a no-effect
threshold level after low-level exposures.
For example, an ionizing tract could pass
through a cellwithout inducing DNAdam-
age or even inducing an epigenetic change.
Depending on the cell the ionizing tract
that exceeds intracellular protective barriers
might still not make a biologic impact that
would lead to an end point of disease.
Specific DNA damage could be repaired in
an error-free manner. The damage that is
not repaired could lead to cell death or
mutation in a stem or progenitor cell. The
same ionizing tract could also alter the
redox state ofa cell. The induced oxidative
stress could trigger signal transduction
mechanisms that, depending on the state of
the cell or the cell type, might activate
genes for differentiation, cell proliferation,
or apoptosis.
Depending on when this low-level
exposure occurs in the course ofdevelop-
ment (e.g., embryogenesis, organogenesis,
neonate, adolescence, adult, or aging adult
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stages), the impact ofagene orchromosomal
mutation or the death ofa cell or an acti-
vated gene also depends on the type ofcell
in which these events occur and on subse-
quent exposures. In theory a single low-level
exposure could set the stage for a subsequent
reaction of the cell to another low-level
exposure or a higher level exposure. In the-
ory another exposure could cause an addi-
tive, synergistic, or antagonistic effect at the
cell level. Additionally, the hierarchical
strata above the cell level could determine
consequences at the organism level.
To date there has been experimental and
epidemiologic evidence that supports an
adaptive response or hormesis (82,83) on
both the cell and organism levels. In other
words cells in vitro or organisms exposed to
low levels ofa physical or chemical agent
had less biologic damage with subsequent
higher level exposure than cells ororganisms
that received the same total dose given
acutely. At each level oforganization there
are possible explanations for such findings.
For example, low-level exposure could
induce signal transduction to activate DNA
repair enzymes, glutathione synthetase, and
other protective or repair mechanisms so
that subsequent exposure to higher levels of
a genotoxicant or cytotoxicant positions the
cell to cope more effectively with any possi-
ble lethal or mutagenic lesion. Whether the
adaptive response on the cell level impacts
on the next higher level would depend on
the cell in which the adaptive response was
noted, whether the adaptive response actu-
ally prevented any stable mutagenic or epi-
genetic event to occur in the surviving cell,
and whether the cell rescued by the adaptive
response actually could be clonally multi-
plied. An abnormal cell such as a carcino-
genic initiated stem cell will have a chance
to effect a pathologic or physiologic change
only ifit is multiplied.
At the cellular level there is evidence that
the adaptive response is mediated by GJIC
(84). Older literature provides observations
that cells irradiated in spheroids are more
radioresistant than those in two-dimensional
contact inhibited environments or in sparse
in vitro conditions (17). As antioxidants
such as glutathione can pass through gap
junctions (85,86), and because glutathione
status ofcells has been correlated with radia-
tion and drug sensitivity (29,30,87-89),
cells that are gap junctionally coupled or
uncoupled could respond to radiation expo-
sures or chemical toxicants. Only a few
studies have been performed on the role of
low levels ofionizing radiation on gap junc-
tions (37). It appears, at least at doses below
0.5 Gy, that the structure ofgap junctions is
normal. Functionality ofthe gap junctions
below 0.5 Gy has not yet been determined.
If radiation, a potential genotoxicant and
cytotoxicant, does not inhibit gap junctions
at doses below 0.5 Gy, then gap junctions
could provide the channels by which impor-
tant antioxidants could aid in the rescue of
the damaged cell or through which the death
signal could pass to induce apoptosis (57).
Ifthe chemical to which the organism
is exposed at the cellular level is not a
genotoxicant but is associated with the
appearance oftumors in rodent assays, it is
probably a cytotoxicant such as chloroform
or an epigenetic agent such as TCDD,
phenobarbital, 12-O-tetradecanoylphor-
bol-13-acetate (TPA), or polychlorinated
biphenyls. These chemicals can all induce
oxidative stress, activate various signal trans-
ducing mechanisms, and modulate GJIC.
Most importantly, in the context of low-
level exposures all known epigenetic and
nongenotoxic cytotoxicants have threshold
levels ofeffects (36,37,76). In other words,
a multicellular organism must be exposed
to a high enough level ofthe nongenotoxi-
cant before the agent will act as a tumor
promoter. The same agents at the cellular
level also exhibit threshold levels before
they modulate GJIC or kill cells (36,90).
The significance ofthis is that just because
one can detect some molecular and bio-
chemical or even cellular response to a
potentially toxic physical agent at a low
level, it does not necessarily follow that
there will be a biologic or disease conse-
quence. In otherwords below the threshold
levels at which nongenotoxic cytotoxicants
can kill cells or epigenetic agents can mod-
ulate GJIC, the cell will restore the redox
state and various cybernetic systems will
bring the cell back to ground state. Clearly
each chemical of this class has its own
unique threshold at which it can modulate
GJIC or kill cells (e.g., TPA, DDT, saccha-
rin) and the species or cell type will respond
differently to the same chemical. Moreover,
to complicate the discussion but put these
generalizations into biologic context, mix-
tures ofthis dass ofnongenotoxic chemicals
can either exhibit additive, antagonistic, or
synergistic interactions at both the cellular
andwhole-organism level (80,81,91).
Usually a sustained chronic exposure to
nongenotoxic chemicals at threshold levels
and above must be maintained in order for
the appearance of a disease state such as
cancer to manifest itself (79). Exceptions
to this generalization would be the acute
exposure to a threshold level of a given
nongenotoxic agent or to a mixture of
nongenotoxicants at a critical period of
embryonic or fetal development (92).
Alteration of the adaptive function ofdif-
ferentiated cells by nongenotoxic agents
at critical times in organogenesis and
development could lead to teratogenesis
(90,92,93).
Implicit in the use ofthe term low-level
exposure is the idea that the adaptive trigger
must be that which exceeds the background
level ofoxidative metabolic and oxidative
stress ofthe cells ofthe organism, but not
high enough to cause negative consequences
to the cell or organisms. The exact dose and
the timing between the adaptive exposure
and the subsequent damaging dose appear
to depend on the system being studied. It is
possible that alowdose ofionizing radiation
could induce transcription ofgenes needed
to protect the cells from subsequent expo-
sure to higher doses by inducing an incre-
ment of oxidative stress above normal
background levels. It is possible that the
induction ofantioxidants, reductants, or
cell-cycle checkpoint inhibitors to facilitate
time for DNA repair could provide a mech-
anism to explain some ofthe reported adap-
tive responses. GJIC has been proposed as a
mediator ofthe adaptive response (94). Ishii
and Watanabe (84) reported recently that
GJIC appears necessary to see an adaptive
response afterX-rayexposure.
In summary the absorption ofradiation's
energybymolecules in stem, progenitor, and
terminally differentiated cells in a multicellu-
lar organism must overcome multiple barri-
ers built into cells, tissues, organs, and organ
systems in order to alter homeostatic control
ofcell proliferation, differentiation, wound
healing, apoptosis, and adaptive responses of
differentiated cells. Ifthe frequency ofthese
end points exceeds the normal background
levels in specific tissues afterexposure, partic-
ularly in normal and/or initiated stem cells,
such exposure could result in disease.
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